Repeat Dosing of Psilocybin in Migraine Headache
Conditions
Headaches
Phase I
Volunteers
Health Professionals
What is the purpose of this trial?
In seeking to understand the capacity for psilocybin to reduce migraine headache burden, this study will investigate single and repeated dosing of psilocybin up to two doses. In seeking to identify an underlying mechanism in psilocybin's effects, neuroinflammatory markers for migraine headache will be measured.
- Ages21 years - 65 years
- GenderBoth
- Trial withWallace Research Foundation
- Start Date01/01/2021
- End Date07/15/2022
I'm interested in volunteering
If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343
Principal Investigator
Sub-Investigator
- Last Updated04/05/2022
- Study HIC#2000026974